FlutiForm HFA MDI 100/10 µg and 250/10 µg

fluticasone propionate/formoterol · SkyePharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FlutiForm HFA MDI 100/10 µg and 250/10 µg, covering 2010-08-27 to 2010-08-27. Get the full timeline:

Most recent: Clinical Trial Update: New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma [Phase 3]